Invention Grant
- Patent Title: Double-stranded oligonucleotide molecules targeting p53 and methods of use thereof
-
Application No.: US15942587Application Date: 2018-04-02
-
Publication No.: US10781449B2Publication Date: 2020-09-22
- Inventor: Elena Feinstein , Sharon Avkin-Nachum , Hagar Kalinski , Igor Mett
- Applicant: QUARK PHARMACEUTICALS, INC.
- Applicant Address: US CA Fremont
- Assignee: QUARK PHARMACEUTICALS, INC.
- Current Assignee: QUARK PHARMACEUTICALS, INC.
- Current Assignee Address: US CA Fremont
- Agency: JMB Davis Ben-David
- Main IPC: C12N15/11
- IPC: C12N15/11 ; C12N15/113
Abstract:
The present application relates to nucleic acid compounds, compositions comprising same and methods of use thereof for treatment of various diseases, disorders and conditions. The compounds are preferably chemically synthesized and modified double-stranded nucleic acid molecules which down regulate expression of a p53 gene.
Public/Granted literature
- US20190040385A1 DOUBLE-STRANDED OLIGONUCLEOTIDE MOLECULES TARGETING P53 AND METHODS OF USE THEREOF Public/Granted day:2019-02-07
Information query
IPC分类:
